LEADER 05481nam  2200697 a 450 
001 9910817058403321
005 20240417000206.0
010   $a1-280-20362-5
010   $a9786610203628
010   $a0-309-55594-9
010   $a0-585-17750-3
035   $a(CKB)111004366660604
035   $a(EBL)3377062
035   $a(SSID)ssj0000119800
035   $a(PQKBManifestationID)11128672
035   $a(PQKBTitleCode)TC0000119800
035   $a(PQKBWorkID)10072920
035   $a(PQKB)11100905
035   $a(MiAaPQ)EBC3377062
035   $a(Au-PeEL)EBL3377062
035   $a(CaPaEBR)ebr10063022
035   $a(OCoLC)923267802
035   $a(EXLCZ)99111004366660604
100   $a19910412d1991      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 04$aThe Changing economics of medical technology /$fAnnetine C. Gelijns and Ethan A. Halm, editors ; Committee on Technological Innovation in Medicine, Institute of Medicine
205   $a1st ed.
210   $aWashington, D.C. $cNational Academy Press$d1991
215   $a1 online resource (224 p.)
225 1 $aMedical innovation at the crossroads ;$vv. 2
300   $aProceedings of a workshop held Dec. 20-21, 1989, supported by the Howard Hughes Medical Institute and the Agency for Health Care Policy and Research of the Dept. of Health and Human Services (grant 5 R09 HS055 26 02).
311   $a0-309-04491-X 
320   $aIncludes bibliographical references and index.
327   $a""The Changing Economics of Medical Technology""; ""Copyright""; ""Acknowledgments""; ""Preface""; ""Contents""; ""List of Abbreviations""; ""1 An Introduction to the Changing Economics of Technological Innovation in Medicine ""; ""A DYNAMIC MODEL OF TECHNOLOGICAL INNOVATION IN MEDICINE""; ""THE DYNAMICS OF PHARMACEUTICAL INNOVATION""; ""THE DYNAMICS OF DEVICE INNOVATION""; ""THE DYNAMICS OF SURGICAL INNOVATION""; ""INTERNATIONAL COMPARISONS: EUROPE AND JAPAN""; ""CONCLUDING OBSERVATIONS""; ""NOTES""; ""REFERENCES""; ""2 The Diffusion of New Technology: Costs and Benefits to Health Care ""
327   $a""HOW MUCH DOES NEW TECHNOLOGY ADD TO HEALTH CARE COSTS?""""OPTIMAL DIFFUSION OF TECHNOLOGY: THE COST-EFFECTIVENESS PRINCIPLE""; ""EFFECTS OF REIMBURSEMENT ON THE USE OF NEW TECHNOLOGIES""; ""Hospitals""; ""HMOs and Managed Care Plans""; ""Incentives for Fee-for-Service Physicians""; ""FUTURE DIRECTIONS: HOW TO ACHIEVE COST-EFFECTIVE DIFFUSION OF MEDICAL TECHNOLOGY""; ""NOTE""; ""REFERENCES""; ""3 The Changing Economics of Pharmaceutical Research and Development ""; ""CURRENT TRENDS""; ""R&D Opportunities""; ""R&D Costs""; ""Product Life Cycles""; ""Effective Patent Life""; ""Drug Prices""
327   $a""RETURN TO PHARMACEUTICAL R&D""""IMPLICATIONS""; ""PUBLIC POLICY CONSIDERATIONS""; ""NOTES""; ""REFERENCES""; ""4 Public Policy and Access to New Drugs: The Case of Cancer Chemotherapy ""; ""CANCER CARE: A SERIES OF INCREMENTAL INNOVATIONS""; ""A PERIOD OF TRANSITION: FROM RAPID GROWTH TO STRICT CONTROL""; ""REIMBURSEMENT POLICIES AND THEIR EFFECT ON THE USE OF NEW TECHNOLOGIES""; ""The Effects of the Prospective Payment System""; ""The Dis-Integration of Care""; ""Growing Patterns of Denial of Payment""; ""Off-Label Use and New Indications""; ""Payment for Investigational Therapies""
327   $a""EFFECTS OF REIMBURSEMENT POLICIES ON INNOVATION""""The Impact of the PPS on Clinical Research""; ""Decreasing Effective Patent Life""; ""GROWING DISINCENTIVES TO PROVIDING STATE-OF-THE-ART CARE""; ""PROSPECTS FOR THE FUTURE""; ""NOTE""; ""REFERENCES""; ""5 The Impact of Public Policy on Medical Device Innovation: A Case of Polyintervention ""; ""THE ASSESSMENT: PUBLIC POLICIES AND MEDICAL DEVICE INNOVATION""; ""The Limits of the Traditional Models of Innovation""; ""The Pivotal Role of Public Policy""; ""THE MEDICAL DEVICE INDUSTRY AS PATIENT""
327   $a""THE EVALUATION: THE IMPACT OF POLYINTERVENTION""""Case Study: Lithotripsy""; ""Case Study: Intraocular Lenses""; ""TREATMENT OPTIONS: IMPROVING THE PUBLIC POLICY ENVIRONMENT""; ""Fine-tuning Individual Policies""; ""Understanding Polyintervention""; ""CONCLUSION""; ""NOTE""; ""REFERENCES""; ""6 The Dynamics of Medical Device Innovation: An Innovator's Perspective ""; ""PATENTS""; ""WHO DOES R&D?""; ""FINANCING OF INNOVATION""; ""REGULATORY DIFFERENCES""; ""THE ROLE OF LIABILITY""; ""REIMBURSEMENT""; ""CONCLUSIONS""; ""SELECTIVE BIBLIOGRAPHY""
327   $a""7 Reimbursement and the Dynamics of Surgical Procedure Innovation ""
410  0$aMedical innovation at the crossroads ;$vv. 2.
606   $aMedical innovations$xEconomic aspects$vCongresses
606   $aPharmaceutical industry$xTechnological innovations$xEconomic aspects$vCongresses
615  0$aMedical innovations$xEconomic aspects
615  0$aPharmaceutical industry$xTechnological innovations$xEconomic aspects
676   $a338.43/61/028
701   $aGelijns$b Annetine$01640409
701   $aHalm$b Ethan A$01724250
712 02$aInstitute of Medicine (U.S.).$bCommittee on Technological Innovation in Medicine.
712 02$aHoward Hughes Medical Institute.
712 02$aUnited States.$bAgency for Health Care Policy and Research.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910817058403321
996   $aThe Changing economics of medical technology$94126199
997   $aUNINA